ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESR01

Electronic Tools to Increase Recognition and Improve Primary Care Management for Hypertension in Chronic Kidney Disease: A Multi-site Randomized Clinical Trial

Active
Institution
BRIGHAM AND WOMEN'S HOSPITAL, MA
Principal investigator
Lipika Samal
Funding
$884K
Duration
2018–2030
Open portfolio

Moonbase score

Still being scored

Abstract

ABSTRACT Chronic kidney disease (CKD) affects 1 in 7 adults in the United States. Despite its high prevalence, approximately 90% of those with kidney disease are not aware they have it. In addition, hypertension (HTN) remains a leading cause of end stage renal disease and greatly impacts the risk for adverse cardiovascular outcomes in the CKD population. Primary care physicians (PCPs) are uniquely positioned to effectively manage CKD through early identification and use of evidence-based treatments, but they face time-constraints and competing demands. Clinical decision support (CDS) tools can bridge that gap by utilizing data within the electronic health record (EHR) to provide recommendations. In our prior work, we incorporated behavioral economic principles and human-centered design in a CDS tool to deliver tailored, actionable, and evidence-based recommendations for the management of HTN within a primary care CKD population. We demonstrated that the CDS had a statistically significant effect on lowering systolic blood pressure (SBP), in addition to increasing prescription for evidence-based renin-angiotensin-aldosterone system inhibitor (RAASi) therapy. In this project, we aim to establish the generalizability of these findings by implementing the CDS tool across three health systems. We will also update the CDS to address medication nonadherence and to incorporate new clinical practice recommendations for sodium glucose co-transporter-2 inhibitors (SGLT2i). The specific aims of this project are to 1) adapt and pilot test CKD CDS in multiple health systems, 2) determine the effectiveness of the CDS alerts on lowering SBP and increasing RAASi/SGLT2i prescriptions in a pragmatic randomized trial in 36 primary care clinics across three health systems and 3) use two implementation frameworks, TAM3 and Proctor’s Implementation Outcomes Framework, to assess implementation outcomes and factors influencing implementation in order to inform further dissemination. In summary, this renewal application seeks to establish the scalability of a CDS tool, based on behavioral nudge alerts, across diverse patient populations and various EHR workflows for the management of HTN in adults with CKD within primary care settings.

Research team

  • Saul B. BleckerPI
  • David Alan FeldsteinPI
  • Lipika SamalPI

LOADING MOONBASE SCORE

R01NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESSpecial Emphasis Panel[ZRG1 HSS-D (90)]alertshealth systemskidney diseaseprimary careckdsbphtncds

Questions for BRIGHAM AND WOMEN'S HOSPITAL

Answered by the team behind this research.

Same institution, same topic, scored first.